OppenheimerFunds’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

OppenheimerFunds’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-36,790	Closed	-$770K	–	1853
2016 Q3	$770K	Buy	+36,790	New	+$424K	﹤0.01%	1096

OppenheimerFunds's VTAE Position: Q4 2016 in Review

OppenheimerFunds sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 36,790 shares — an estimated $770K sold.

OppenheimerFunds first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $770K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

OppenheimerFunds reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
OppenheimerFunds sold 36,790 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $770K.
OppenheimerFunds first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
OppenheimerFunds's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $770K in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on OppenheimerFunds's 13F filing for Q4 2016, filed 14 Feb 2017.